LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

38.91 -3.97

Buy Sell

Overview

Share price change

24h

Current

Min

38.65

Max

40.67

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	12.278 77.671
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	14M 73M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+13.55% upside

Market Stats
By TradingEconomics
Market Cap	554M 2.2B
Previous open	42.88
Previous close	38.91

News Sentiment

By Acuity

34%

66%

96 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 gru 2025, 17:39 UTC

Major Market Movers

Vanda Pharmaceuticals Rises on FDA Biologics License Application

15 gru 2025, 23:44 UTC

Market Talk

Gold Steady Ahead of U.S. Employment Report -- Market Talk

15 gru 2025, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

15 gru 2025, 23:38 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

15 gru 2025, 22:19 UTC

Market Talk

Clean-Energy Project Developers Benefit From 'Deep Buyer Universe' -- Market Talk

15 gru 2025, 21:50 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

15 gru 2025, 21:42 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Modest Valuation, a Signal for a Warner Bros. Sale -- Barrons.com

15 gru 2025, 21:32 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Modest Valuation, Puts Warner Bros. Discovery in Focus -- Barrons.com

15 gru 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

iRobot Files for Bankruptcy After Amazon Was Forced to Scrap Its Deal to Buy the Roomba Maker -- Barrons.com

15 gru 2025, 21:26 UTC

Acquisitions, Mergers, Takeovers

Commercial Metals Completes Acquisition of Foley Products for $1.84B >CMC

15 gru 2025, 21:23 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Reserves Right to Make Further Proposal If Circumstances Change

15 gru 2025, 21:23 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Does Not Intend to Submit Revised Takeover Proposal For Predictive

15 gru 2025, 21:23 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Notes Predictive Shares Trade at Discount to Value Implied By Perseus Proposal

15 gru 2025, 21:22 UTC

Acquisitions, Mergers, Takeovers

Perseus Mining: Believes Revised Robex Merger Inferior to Its Own Takeover Proposal

15 gru 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

Commercial Metals Completes Acquisition Of Foley Products Company >CMC

15 gru 2025, 21:15 UTC

Acquisitions, Mergers, Takeovers

ServiceNow Completes Acquisition Of Moveworks >NOW

15 gru 2025, 21:00 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

15 gru 2025, 20:57 UTC

Acquisitions, Mergers, Takeovers

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

15 gru 2025, 20:36 UTC

Market Talk

Oil Futures Fall Further on Oversupply Concerns -- Market Talk

15 gru 2025, 20:31 UTC

Market Talk

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

15 gru 2025, 20:27 UTC

Market Talk

Acquisitions, Mergers, Takeovers

ServiceNow's Acquisition Streak Could Cause Investor Angst -- Market Talk

15 gru 2025, 20:15 UTC

Market Talk

El Buen Fin Helps Lift Mexican November Retail Sales -- Market Talk

15 gru 2025, 19:22 UTC

Market Talk

Gold and Silver Gain to Start Week -- Market Talk

15 gru 2025, 18:37 UTC

Market Talk

Oil Futures Extend Losses On Oversupply Worries -- Market Talk

15 gru 2025, 18:29 UTC

Market Talk

ServiceNow Seen Facing Pressure if Government Budgets Decline -- Market Talk

15 gru 2025, 17:58 UTC

Market Talk

Canada Housing Market In Search Of a Bottom -- Market Talk

15 gru 2025, 17:36 UTC

Market Talk

Canada Data Signal Underlying Price Pressures Persist -- Market Talk

15 gru 2025, 17:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 gru 2025, 17:36 UTC

Earnings

Texas Instruments Stock Slips. It Caught a Rare Downgrade From Goldman Sachs. -- Barrons.com

15 gru 2025, 17:30 UTC

Acquisitions, Mergers, Takeovers

Cinemark Stock Could Fall Even More If Netflix Buys Warner Bros., Analyst Says -- Barrons.com

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

13.55% upside

12 Months Forecast

Average 46 USD 13.55%

High 62 USD

Low 32 USD

Based on 10 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

Buy

Hold

Sell

Based on 10 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

96 / 374 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.